...
首页> 外文期刊>Drugs and aging >What causes some patients with drug-induced QT interval prolongation to develop torsades de pointes but not others? The elusive missing link
【24h】

What causes some patients with drug-induced QT interval prolongation to develop torsades de pointes but not others? The elusive missing link

机译:是什么原因导致某些药物引起的QT间隔延长的患者发展成尖端扭转型室速而不是其他患者?难以捉摸的缺失链接

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Cardiac arrest due to torsades de pointes (TdP) is an uncommon but potentially catastrophic event associated with QT interval-prolonging drugs [1], Numerous medications that may cause TdP are available for use in clinical practice, and include drugs for management of cardiovascular diseases, primarily arrhythmias, but also noncardio-vascular agents from multiple classes, including anti-infectives, antipsychotics, antidepressants, methadone, and many more [2]. The risk of TdP increases as the heart rate-corrected QT (QTC) interval increases [3-6], particularly when it exceeds 500 ms [5, 6].
机译:尖端扭转型室速(TdP)引起的心脏骤停是罕见的,但可能与QT间期延长药物有关[1]。具有多种可能导致TdP的药物可用于临床,包括用于治疗心血管疾病的药物,主要是心律不齐,也包括多种类别的非心血管药物,包括抗感染药,抗精神病药,抗抑郁药,美沙酮等[2]。随着心率校正QT(QTC)间隔的增加,TdP的风险也会增加[3-6],尤其是当其超过500 ms时[5,6]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号